Literature DB >> 24425652

The development of new anticancer drugs.

F M Arcamone1.   

Abstract

Year:  1992        PMID： 24425652     DOI： 10.1007/BF02421499

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN： 0959-3993            Impact factor:   3.312


× No keyword cloud information.
  26 in total

1.  Association of anthracyclines and synthetic hexanucleotides. Structural factors influencing sequence specificity.

Authors:  V Rizzo; C Battistini; A Vigevani; N Sacchi; G Razzano; F Arcamone; A Garbesi; F P Colonna; M Capobianco; L Tondelli
Journal:  J Mol Recognit       Date:  1989-11       Impact factor: 2.137

Review 2.  Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material.

Authors:  C Zimmer; U Wähnert
Journal:  Prog Biophys Mol Biol       Date:  1986       Impact factor: 3.667

Review 3.  DNA topoisomerase II: a primer on the enzyme and its unique role as a multidrug target in cancer chemotherapy.

Authors:  B S Glisson; W E Ross
Journal:  Pharmacol Ther       Date:  1987       Impact factor: 12.310

Review 4.  Chemical approaches in anticancer drug development.

Authors:  F Arcamone
Journal:  Cancer Treat Rev       Date:  1988-03       Impact factor: 12.111

5.  Joint experimental and theoretical investigation of the comparative DNA binding affinities of intercalating anthracycline derivatives.

Authors:  N Gresh; B Pullman; F Arcamone; M Menozzi; R Tonani
Journal:  Mol Pharmacol       Date:  1989-02       Impact factor: 4.436

6.  Interaction of anthracycline antibiotics with biopolymers. VIII. Binding parameters of aclacinomycin A to DNA.

Authors:  U Katenkamp; E Stutter; I Petri; F A Gollmick; H Berg
Journal:  J Antibiot (Tokyo)       Date:  1983-09       Impact factor: 2.649

7.  DNA-drug interactions. The crystal structure of d(CGATCG) complexed with daunomycin.

Authors:  M H Moore; W N Hunter; B L d'Estaintot; O Kennard
Journal:  J Mol Biol       Date:  1989-04-20       Impact factor: 5.469

8.  In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.

Authors:  Y Ohe; K Nakagawa; Y Fujiwara; Y Sasaki; K Minato; M Bungo; S Niimi; N Horichi; M Fukuda; N Saijo
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

9.  Anthracycline-DNA interactions studied with linear dichroism and fluorescence spectroscopy.

Authors:  M Eriksson; B Nordén; S Eriksson
Journal:  Biochemistry       Date:  1988-10-18       Impact factor: 3.162

10.  Site and sequence specificity of the daunomycin-DNA interaction.

Authors:  J B Chaires; K R Fox; J E Herrera; M Britt; M J Waring
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.